DSM-Firmenich AG (AMS: DSFIR)

Netherlands flag Netherlands · Delayed Price · Currency is EUR
98.88
-0.20 (-0.20%)
Jan 21, 2025, 5:36 PM CET
8.81%
Market Cap 26.08B
Revenue (ttm) 12.46B
Net Income (ttm) -188.00M
Shares Out 263.78M
EPS (ttm) -0.71
PE Ratio n/a
Forward PE 26.10
Dividend 0.93 (0.94%)
Ex-Dividend Date May 9, 2024
Volume 320,784
Average Volume 356,108
Open 99.20
Previous Close 99.08
Day's Range 98.44 - 99.20
52-Week Range 87.96 - 124.85
Beta n/a
RSI 51.66
Earnings Date Feb 13, 2025

About DSM-Firmenich AG

DSM-Firmenich AG provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. It operates through Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and s... [Read more]

Sector Materials
Founded 1902
Employees 28,685
Stock Exchange Euronext Amsterdam
Ticker Symbol DSFIR
Full Company Profile

Financial Performance

In 2023, DSM-Firmenich AG's revenue was 10.63 billion, an increase of 26.66% compared to the previous year's 8.39 billion. Earnings were 2.13 billion, an increase of 25.80%.

Financial Statements

News

Reducing Cattle’s Footprint

Cow flatulence is a significant contributor to the greenhouse gas in our atmosphere. Dutch company DSM-Firmenich’s Bovaer addresses that issue at source: The feed additive slows down the last step of ...

2 months ago - TIME

Pavel Bittner birla por una llanta un sprint de foto-finish a Van Aert

El joven checo de 21 aos, del Team DSM-Firmenich, logr su tercera victoria de etapa como profesional

5 months ago - La Vanguardia

DSM-Firmenich AG (KDSKF) Q2 2024 Earnings Call Transcript

DSM-Firmenich AG (OTC:KDSKF) Q2 2024 Earnings Conference Call July 30, 2024 3:00 AM ET Company Participants Dave Huizing - Head of Investor Relations Dimitri de Vreeze - Chief Executive Officer Ralf S...

6 months ago - Seeking Alpha

DSM-Firmenich AG (KDSKF) Q1 2024 Earnings Call Transcript

DSM-Firmenich AG (OTC:KDSKF) Q1 2024 Earnings Conference Call May 2, 2024 3:00 AM ET Company Participants Dave Huizing - Head of Investor Relations Ralf Schmeitz - Chief Financial Officer Conference C...

9 months ago - Seeking Alpha

Royal DSM: Quality At A Price

Royal DSM has proven its resilience through the near-term macro challenges. Its upcoming merger with Firmenich also appears promising and could deliver upside going forward.

2 years ago - Seeking Alpha

Koninklijke DSM N.V. (RDSMY) CEO Geraldine Matchett on Q2 2022 Results - Earnings Call Transcript

Koninklijke DSM N.V. (OTCQX:RDSMY) Q2 2022 Results Conference Call August 2, 2022 8:00 AM ET Company Participants Dave Huizing - Vice President of Investor Relations Geraldine Matchett - Chief Executi...

2 years ago - Seeking Alpha

Health and biotech firm says it has enjoyed resilient demand as health kick is here to stay

Dimitri de Vreeze, co-CEO of DSM, discusses his company's earnings and explains why demand has remained strong.

2 years ago - CNBC International TV

'A merger of equals': Firmenich CEO Ghostine on DSM deal

Firmenich CEO Gilbert Ghostine describes the company's deal with sector peer DSM as a "merger of equals."

2 years ago - CNBC International TV

5 Great Green Stocks Making a Direct Impact

It's the end of business as usual. To save the planet, consumers, companies and governments all over the world are stepping up their sustainability game, or at least pledging to do so.

3 years ago - Kiplinger

Koninklijke DSM N.V. (RDSMY) on Q4 and FY 2021 Results - Earnings Call Transcript

Koninklijke DSM N.V. (RDSMY) on Q4 and FY 2021 Results - Earnings Call Transcript

3 years ago - Seeking Alpha

DSM co-CEO: Inflationary pressures offset by 4% price increase in some business areas

Geraldine Matchett, co-CEO of DSM and member of CNBC's ESG Council, provides a deep dive into the company's fourth-quarter results and shares how DSM are tackling rising inflation.

3 years ago - CNBC International TV

Very Confident to Increase Our Outlook: DSM Co-CEO

Aug.04 -- DSM Co-CEO Dimitri de Vreeze discusses the company's earnings, emissions and sustainable foods. He speaks with Bloomberg's Anna Edwards and Mark Cudmore on "Bloomberg: European Market Open".

3 years ago - Bloomberg Markets and Finance

Koninklijke DSM NV (RDSMY) CEO Dimitri de Vreeze on Q4 2020 Results - Earnings Call Transcript

Koninklijke DSM NV (RDSMY) CEO Dimitri de Vreeze on Q4 2020 Results - Earnings Call Transcript

4 years ago - Seeking Alpha

DSM Going Into 2021 With Positive Momentum, Says Co-CEO

Feb.16 -- Geraldine Matchett, co-chief executive officer at at Dutch Lifesciences company Koninklijke DSM NV, discusses fourth-quarter earnings, the animal nutrition business and her outlook for the b...

4 years ago - Bloomberg Markets and Finance

Koninklijke DSM N.V. (RDSMY) Dimitri de Vreeze on Q3 2020 Results - Earnings Call Transcript

Koninklijke DSM N.V. (RDSMY) Dimitri de Vreeze on Q3 2020 Results - Earnings Call Transcript

4 years ago - Seeking Alpha

'Analysts failed to see the impact of foreign exchange headwinds on top line,' DSM co-CEO says

Geraldine Matchett and Dimitri de Vreeze, co-CEOs at DSM, discuss the company's third-quarter earnings and the impact of the pandemic on the business.

4 years ago - CNBC International TV

Koninklijke DSM N.V. (RDSMY) Dimitri Vreeze on Q2 2020 Results - Earnings Call Transcript

Koninklijke DSM N.V. (RDSMY) Dimitri Vreeze on Q2 2020 Results - Earnings Call Transcript

4 years ago - Seeking Alpha

DSM co-CEO's say cash generation 'is a big focus' amid the coronavirus crisis

Geraldine Matchett and Dimitri de Vreeze, co-CEO's of DSM, speak to the corporation's first half of the year along with its strategy amid the uncertainty of a second wave.

4 years ago - CNBC International TV

Koninklijke DSM NV (RDSMY) Q1 2020 Results - Earnings Call Transcript

Koninklijke DSM NV (RDSMY) Q1 2020 Results - Earnings Call Transcript

5 years ago - Seeking Alpha

Koninklijke DSM N.V. (RDSMY) CEO Feike Sijbesma on Q4 2019 Results - Earnings Call Transcript

Koninklijke DSM N.V. (RDSMY) CEO Feike Sijbesma on Q4 2019 Results - Earnings Call Transcript

5 years ago - Seeking Alpha

Koninklijke DSM N.V. (RDSMY) Management on Q3 2019 Results - Earnings Call Transcript

Koninklijke DSM N.V. (RDSMY) Management on Q3 2019 Results - Earnings Call Transcript

5 years ago - Seeking Alpha